#OrigAMI1
LightNews LightNews
oncodaily.bsky.social
ESMO GI 2025 Highlights: OrigAMI-1 Trial on Amivantamab Rechallenge in mCRC
@myesmo.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOGI25 #OrigAMI1 #Amivantamab #mCRC #GIOnc
OrigAMI-1 Trial at ESMO GI 2025: Amivantamab in mCRC
The OrigAMI-1 trial explored the efficacy of amivantamab monotherapy in left-sided RAS/BRAF wild-type metastatic colorectal cancer (mCRC).
oncodaily.com
July 3, 2025 at 10:04 PM
misano.bsky.social
簡単だし可愛い。

こちらを参考にしました。

折り紙　カードケース　簡単な折り方 origami1.net/1629.html
December 7, 2024 at 8:26 AM
longtail-news.bsky.social
Feed: "Oncodaily | Oncology News, Insights, Stories"
Published on Friday, July 18, 2025
Akhil Santhosh: OrigAMI1 – The Effect of Amivantamab in Previously Treated RAS Wild Colon Cancer
Akhil Santhosh: OrigAMI1 - The Effect of Amivantamab in Previously Treated RAS Wild Colon Cancer / Akhil Santhosh, Amivantamab, cancer, Colon cancer,
oncodaily.com
July 19, 2025 at 1:50 AM